Statistical Power to Detect an Association Between Guideline-based Palivizumab Administration and Hospitalizations for Respiratory Syncytial Virus Infections

類似資料

• Rebuttal: palivizumab for the prevention of respiratory syncytial virus infection
  著者:: Smart, Kelly A., 等
  出版事項: (2010)
• Palivizumab for the prevention of respiratory syncytial virus infection
  著者:: Rogovik, Alexander L., 等
  出版事項: (2010)
• Respiratory syncytial virus and palivizumab prophylaxis in the COVID-19 era
  著者:: Taylor, Richard S.
  出版事項: (2021)
• Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis
  著者:: Heikkinen, T, 等
  出版事項: (2005)
• In Vivo Selection of Respiratory Syncytial Viruses Resistant to Palivizumab
  著者:: Zhao, Xiaodong, 等
  出版事項: (2005)